首页> 外文学位 >MiRNA profiling of tumor-derived exosomes.
【24h】

MiRNA profiling of tumor-derived exosomes.

机译:肿瘤来源的外泌体的MiRNA分析。

获取原文
获取原文并翻译 | 示例

摘要

Cancers and infectious diseases are becoming a growing public health problem in the world today. The importance of my work for public health is in detecting these diseases earlier and more accurately, potentially leading to better therapies and higher survival rates for patients. Current diagnostic techniques focus on detecting antibodies from serum, gene expression and miRNA profiles of tumor tissues and, more recently, in the bodily fluids of patients.;This dissertation shows a novel technique that makes use of small microvesicles called exosomes and the microRNAs (miRNAs) they carry for the potential diagnosis of cancer. Exosomes are small (40-100 nm) membrane-bound vesicles that are created from the inverse budding of the multivesicular endosome and originate from a variety of tumor types. Exosomes can be easily purified from cell cultures and serum of patients and have recently been shown to carry small non-coding RNAs called miRNAs. In the first part of this study, I developed techniques that enabled us to increase the amount of our exosome and total RNA starting material before proceeding to use these as potential diagnostics for head and neck cancers.;Although the use of exosomes to diagnose diseases is not novel, the use of miRNAs present in tumor-derived exosomes is a new approach. In the final two chapters, I discuss the use of exosomes to diagnose KSHV viral infections as well as head and neck cancer. Increasing the accuracy and reducing the amount of starting material needed for these studies would provide a non-invasive technique to detect viral infections and cancers. This would help in providing earlier therapeutic treatments and help to increase the longevity and quality of life of patients.
机译:当今世界,癌症和传染病正成为日益严重的公共卫生问题。我的工作对公共卫生的重要性在于更早,更准确地发现这些疾病,有可能导致更好的治疗方法和更高的患者生存率。当前的诊断技术着重于从肿瘤组织的血清,基因表达和miRNA谱中检测抗体,以及最近在患者的体液中检测抗体。本论文展示了一种利用称为外泌体和microRNA(miRNA)的小型微囊泡的新技术。 )可以进行癌症的潜在诊断。外泌体是膜结合的小囊泡(40-100 nm),由多囊泡内体的逆芽形成,起源于多种肿瘤类型。外泌体可以很容易地从患者的细胞培养物和血清中纯化,并且最近显示出携带称为miRNA的小的非编码RNA。在本研究的第一部分中,我开发了使我们能够增加外泌体和总RNA起始物质的量的技术,然后再将其用作头颈癌的潜在诊断方法;尽管使用外泌体来诊断疾病是肿瘤来源的外泌体中存在的miRNA的使用不是一种新方法,而是一种新方法。在最后两章中,我讨论了使用外泌体诊断KSHV病毒感染以及头颈癌的方法。这些研究需要提高准确性并减少起始材料的数量,这将提供一种检测病毒感染和癌症的非侵入性技术。这将有助于提供更早的治疗方法,并有助于增加患者的寿命和生活质量。

著录项

  • 作者

    Vitrant, David-Georges.;

  • 作者单位

    University of Pittsburgh.;

  • 授予单位 University of Pittsburgh.;
  • 学科 Biology Genetics.;Health Sciences Oncology.;Health Sciences Immunology.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 109 p.
  • 总页数 109
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:37:18

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号